Synonyms: | |
Status: | Approved |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
ATC: | N05CH01 |
UNII: | JL5DK93RCL |
InChI Key | DRLFMBDRBRZALE-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C13H16N2O2 |
Molecular Weight | 232.28 |
AlogP | 1.86 |
Hydrogen Bond Acceptor | 2.0 |
Hydrogen Bond Donor | 2.0 |
Number of Rotational Bond | 4.0 |
Polar Surface Area | 54.12 |
Molecular species | NEUTRAL |
Aromatic Rings | 2.0 |
Heavy Atoms | 17.0 |
Action | Mechanism of Action | Reference |
---|---|---|
AGONIST | Melatonin receptor agonist | Other |
Primary Target | |
---|---|
MT1 receptor | |
MT2 receptor |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Cytochrome P450
Cytochrome P450 family 1
Cytochrome P450 family 1A
Cytochrome P450 1A1
|
- | - | - | 59000 | - | |
Enzyme
Cytochrome P450
Cytochrome P450 family 1
Cytochrome P450 family 1A
Cytochrome P450 1A2
|
- | - | - | 12000 | - | |
Enzyme
Cytochrome P450
Cytochrome P450 family 1
Cytochrome P450 family 1B
Cytochrome P450 1B1
|
- | - | - | 14000 | - | |
Enzyme
Hydrolase
|
- | - | - | - | 1 | |
Enzyme
Oxidoreductase
|
- | 65-11300 | - | 28-57 | - | |
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine-derivative receptor (family A GPCR)
Melatonin receptor
|
0-25 | 0-1 | 0 | 0-1 | 100 | |
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Histamine receptor
|
- | - | - | 1 | - | |
Membrane receptor
|
0-25 | 0-1 | 0 | 0-1 | 19-49 | |
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 71 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Barrett Esophagus | 3 | D001471 | ClinicalTrials |
Depressive Disorder | 3 | D003866 | ClinicalTrials |
Neoplasms | 3 | D009369 | ClinicalTrials |
Migraine Disorders | 3 | D008881 | ClinicalTrials |
Schizophrenia | 3 | D012559 | ClinicalTrials |
Carcinoma, Non-Small-Cell Lung | 3 | D002289 | ClinicalTrials |
Anxiety | 3 | D001007 | ClinicalTrials |
Breast Neoplasms | 3 | D001943 | ClinicalTrials |
Attention Deficit Disorder with Hyperactivity | 3 | D001289 | ClinicalTrials |
Sleep Initiation and Maintenance Disorders | 3 | D007319 | ClinicalTrials |
Child Development Disorders, Pervasive | 3 | D002659 | ClinicalTrials |
Tooth Diseases | 3 | D014076 | ClinicalTrials |
Gastroesophageal Reflux | 3 | D005764 | ClinicalTrials |
Irritable Bowel Syndrome | 3 | D043183 | ClinicalTrials |
Dementia | 3 | D003704 | ClinicalTrials |
Delirium | 3 | D003693 | ClinicalTrials |
Sleep Wake Disorders | 3 | D012893 | ClinicalTrials |
Squamous Cell Carcinoma of Head and Neck | 3 | D000077195 | ClinicalTrials |
Neoplasms | 3 | D009369 | ClinicalTrials |
Enuresis | 2 | D004775 | ClinicalTrials |
Aortic Aneurysm | 2 | D001014 | ClinicalTrials |
Metabolic Syndrome | 2 | D024821 | ClinicalTrials |
Dermatitis, Atopic | 2 | D003876 | ClinicalTrials |
Epilepsy | 2 | D004827 | ClinicalTrials |
Colitis, Ulcerative | 2 | D003093 | ClinicalTrials |
Hypertension | 2 | D006973 | ClinicalTrials |
Multiple Sclerosis, Relapsing-Remitting | 2 | D020529 | ClinicalTrials |
Atrial Fibrillation | 2 | D001281 | ClinicalTrials |
Hemorrhage | 2 | D006470 | ClinicalTrials |
Autistic Disorder | 2 | D001321 | ClinicalTrials |
Pain | 2 | D010146 | ClinicalTrials |
Cognitive Dysfunction | 2 | D060825 | ClinicalTrials |
Melanoma | 2 | D008545 | ClinicalTrials |
Reperfusion Injury | 2 | D015427 | ClinicalTrials |
Fibromyalgia | 2 | D005356 | ClinicalTrials |
Head and Neck Neoplasms | 2 | D006258 | ClinicalTrials |
Burns | 2 | D002056 | ClinicalTrials |
Prediabetic State | 2 | D011236 | ClinicalTrials |
Fatigue | 2 | D005221 | ClinicalTrials |
Parkinson Disease | 2 | D010300 | ClinicalTrials |
Depressive Disorder, Major | 2 | D003865 | ClinicalTrials |
Alcohol-Related Disorders | 2 | D019973 | ClinicalTrials |
Severe Acute Respiratory Syndrome | 2 | D045169 | ClinicalTrials |
Periodontitis | 2 | D010518 | ClinicalTrials |
Myocardial Infarction | 2 | D009203 | ClinicalTrials |
Substance Withdrawal Syndrome | 1 | D013375 | ClinicalTrials |
Hypoxia-Ischemia, Brain | 1 | D020925 | ClinicalTrials |
Postpartum Hemorrhage | 1 | D006473 | ClinicalTrials |
Skin Diseases | 1 | D012871 | ClinicalTrials |
Stomatitis | 1 | D013280 | ClinicalTrials |
Hot Flashes | 1 | D019584 | ClinicalTrials |
Periodontal Diseases | 1 | D010510 | ClinicalTrials |
Brain Ischemia | 1 | D002545 | ClinicalTrials |
Metabolic Diseases | 1 | D008659 | ClinicalTrials |
Multiple Sclerosis | 1 | D009103 | ClinicalTrials |
Sepsis | 1 | D018805 | ClinicalTrials |
Neonatal Sepsis | 1 | D000071074 | ClinicalTrials |
Sunburn | 1 | D013471 | ClinicalTrials |
Bone Diseases, Metabolic | 0 | D001851 | ClinicalTrials |
Diabetes Mellitus | 0 | D003920 | ClinicalTrials |
Sleep Apnea, Obstructive | 0 | D020181 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 73-31-4 |
ChEBI | 16796 |
ChEMBL | CHEMBL45 |
DrugBank | DB01065 |
DrugCentral | 1672 |
EPA CompTox | DTXSID1022421 |
FDA SRS | JL5DK93RCL |
Human Metabolome Database | HMDB0001389 |
Guide to Pharmacology | 1357 |
KEGG | C01598 |
PDB | ML1 |
PharmGKB | PA164752558 |
PubChem | 896 |
SureChEMBL | SCHEMBL19018 |
ZINC | ZINC000000057060 |